HEATHER MARTIN: Open Payments
NPI 1083278279 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 49 payments from 12 companies in 2025. Trend: 2023 $1,413 · 2024 $1,658 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 18 | $641 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $143 |
| Novo Nordisk Inc | 4 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Lilly USA, LLC | 4 | $63 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| ABBVIE INC. | 1 | $24 |
| PFIZER INC. | 1 | $16 |
Products named: FARAPULSE, WATCHMAN FLX, Kerendia, XIFAXAN, MOUNJARO, Wegovy, TRELEGY ELLIPTA, LEQVIO.
Industry payments across SC — which companies pay providers there.
